Contribution of adenosine A2A receptor agonist and antagonist on ovarian ischemia/reperfusion injury in rats

  • Turk J Med Sci. 2025 Dec 31;56(1):364-376. doi: 10.55730/1300-0144.6170.
Azad Mammadov  1 ,  Abdullah Tuncay Demiryürek  1 ,  Ahmet Saracaloğlu  1 ,  Cahit Demirkiran  1 ,  İsmail Tuncer Değim  2 ,  Ömer Eronat  3 ,  Şeniz Demiryürek  4
Affiliations
  • 1. Department of Medical Pharmacology, Faculty of Medicine, Gaziantep University, Gaziantep, Turkiye.
  • 2. Department of Pharmaceutical Technology, Faculty of Pharmacy, Biruni University, İstanbul, Turkiye.
  • 3. Department of Medical Pathology, Faculty of Medicine, Gaziantep University, Gaziantep, Turkiye.
  • 4. Department of Physiology, Faculty of Medicine, Gaziantep University, Gaziantep, Turkiye.
PMID: 41816720 DOI: 10.55730/1300-0144.6170
Abstract

Background/aim: To determine the effects of an A2A receptor agonist regadenoson, an A2A receptor antagonist istradefylline, and istradefylline nanosuspension on ovarian ischemia/reperfusion (I/R) injury in rats.

Materials and methods: A total of 80 female rats were divided into 10 groups: sham, ovarian I/R, blank nanosuspension + ovarian I/R, regadenoson (3 μg/kg) + ovarian I/R, regadenoson (30 μg/kg) + ovarian I/R, istradefylline (0.3 mg/kg) + ovarian I/R, istradefylline (3 mg/kg) + ovarian I/R, istradefylline-loaded nanosuspension (3 mg/kg) + ovarian I/R, istradefylline (3 mg/kg) + regadenoson (30 μg/kg) + ovarian I/R, and istradefylline-loaded nanosuspension (3 mg/kg) + regadenoson (30 μg/kg) + ovarian I/R. ELISA, chemiluminescence, and spectrophotometric analyses were performed on blood and ovarian tissue samples. Histopathological changes were analyzed using hematoxylin and eosin staining, and a scoring system was applied to assess ovarian tissue damage.

Results: Serum malondialdehyde levels were augmented in the I/R and blank nanosuspension + I/R groups. Although tissue superoxide dismutase levels were decreased with I/R, these levels were increased with regadenoson (3 μg/kg), istradefylline (0.3-3 mg/kg), and istradefylline nanosuspension (3 mg/kg). While there was augmentation in the serum and tissue 3-nitrotyrosine levels in the I/R group, a marked decrease was identified with regadenoson (30 μg/kg, p < 0.05). Native thiol levels were decreased in the I/R group, and this decrease was prevented by regadenoson. Serum disulfide levels were increased in the I/R group, and this increase was suppressed by regadenoson.

Conclusion: These data showed that adenosine A2A receptors may contribute to the ovarian I/R injury and regadenoson can produce protective effects.

Keywords
Adenosine receptor; ischemia/reperfusion; istradefylline; ovary; regadenoson.
Products